<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">ZuWallack, Richard</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">New Bronchodilation Treatments for COPD</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">10-11</style></pages><abstract><style  face="normal" font="default" size="100%">This article presents the results 3 clinical trials for the treatment of chronic obstructive pulmonary disease (COPD). Specific studies include the ANHELTO 1 [NCT01694771] and 2 [NCT01696058] trial that evaluated tiotropium + olodaterol, the [GOLDEN-2; NCT01706536] study evaluating the efficacy and safety of twice-daily treatment of SUN-101, as well as LAS-MD-38 [NCT01045161] evaluating twice-daily aclidinium bromide.</style></abstract><number><style face="normal" font="default" size="100%">45</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>